Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 185283 | 20-HETE | 79551-86-3 | >98% |  |
| 20-HETE is a cytochrome P450 (CYP450) metabolite postulated to play an autacoid role | ||||
| 184122 | HMN-154 | 173528-92-2 | >98% |  |
| HMN-154 is a benzenesulfonamide anticancer agent. HMN-154 inhibits DNA binding of NF- | ||||
| 1710133 | HJC0152 | 1420290-99-8 | >98% |  |
| HJC0152 is a signal transducer and activator of transcription 3 (STAT3) inhibitor aga | ||||
| 1791313 | 9-Hydroxyellipticin(free base) | 51131-85-2 | 98.0% | -cas-51131-85-2.png) |
| 9-hydroxyellipticine, also known as IGIG 929 and LS133324, is a potent cytotoxic and | ||||
| 179822 | H3B-6527 | 1702259-66-2 | 98.0% |  |
| H3B-6527 is a potent and orally active FGFR4 inhibitor with potential antineoplastic | ||||
| 1781503 | 1H-pyrazolo[3,4-c]pyridine | 271-47-6 | 96.0% |  |
| 1H-pyrazolo[3,4-c]pyridine | ||||
| 178815 | H-89 Dihydrochloride | 130964-39-5 | 98.0% |  |
| H-89 is a specific adenylyl cyclase inhibitor (DDA) and a cyclic AMP-dependent protei | ||||
| 2017872 | HDM201 | 1448867-41-1 | 98.0% |  |
| HDM201 is an orally bioavailable human double minute 2 homolog (HDM2) inhibitor with | ||||
| 17022709 | HM-61713 (BI-1482694) | 1802181-20-9 | 98% | |
| BI-1482694, is a potent small molecule inhibitor of Bruton's tyrosine kinase (BTK). | ||||
| 17021403 | 5-hydroxypyrazine-2-carboxylic acid | 34604-60-9 | 98% |  |
| 5-hydroxypyrazine-2-carboxylic acid , a metabolite of anti-tuberculosis drug pyrazina | ||||
| 17011902 | Hesperadin | 422513-13-1 | 98% |  |
| Hesperadin is an inhibitor of human Aurora B, which can prevent the phosphorylation o | ||||
| 16122819 | HLCL-61 HCl | 1158279-20-9 | 98% |  |
| HLCL-61 is a potent and selective PRMT5 inhibitor for treatment of acute myeloid leuk | ||||
| 16122818 | Hexaminolevulinate HCl | 140898-91-5 | 98% |  |
| Hexaminolevulinate hydrochloride, also known as hexyl 5-aminolevulinate HCl, is the h | ||||
| 16122816 | HA15 | 1609402-14-3 | 98% |  |
| HA15 displayed anti-cancerous activity on all melanoma cells tested, including cells | ||||
| 161009024 | Honokiol | 35354-74-6 | 98% by HPLC |  |
| Houpu has traditionally been used in Eastern medicine as analgesic and to treat anxie | ||||
| 161009001 | HS-173 | 1276110-06-5 | 98% by HPLC |  |
| HS-173 inhibited the PI3K signaling pathway, and showed anti-proliferative effects on | ||||
| 16062902 | HUHS015 | 1453097-13-6 | 98% by HPLC |  |
| HUHS015 is a potent PCA-1/ALKBH3 inhibitor both in vitro and in vivo. The bioavailabi | ||||
| 16062204 | HLCL-61 | 586395-74-6 | 98% by HPLC |  |
| HLCL-61 is a potent and selective PRMT5 inhibitor for treatment of acute myeloid leuk | ||||
| 032511 | 1H-Pyrrolo[2,3-B]Pyridine-3-Carboxylic Acid | 156270-06-3 | 98% |  |
| Coming soon! | ||||
| 032503 | 1H-Indazole-5-boronic acid | 338454-14-1 | 98% |  |
| Coming soon! | ||||
| 011306 | HTH-01-015 | 1613724-42-7 | 98% |  |
| HTH-01-015 is a potent and selective inhibitor of NUAK1 with IC50 of 100 nM, does not | ||||
| 010402 | hydrocortisone | 50-23-7 | 98% |  |
| Hydrocortisone is the main glucocorticoid secreted by the ADRENAL CORTEX. Its synthet | ||||
| 121507 | HQL-79 | 162641-16-9 | 98% |  |
| Coming soon! | ||||
| 103003 | HBED-CC-PSMA ( PSMA-11 ) | 1366302-52-4 | 97% | _1366302-52-4.png) |
| PSMA-11, also known as HBED-CC-PSMA or Psma-hbed-CC, has potential use as a tracer fo | ||||
| 103002 | HBED-CC | 143557-99-7 | 98.0% |  |
| Coming soon! | ||||
| 92218 | 6-hydroxy-N-Methylbenzofuran-3-carboxaMide | 98% |  | |
| Coming soon! | ||||
| 91706 | 7-hydroxy-1H-quinolin-2-one | 70500-72-0 | 98% |  |
| Coming soon! | ||||
| 90608 | 3-(4-Hydroxyphenyl)propionic acid | 501-97-3 | 98% | propionicacid-cas-501-97-3.png) |
| Coming soon! | ||||
| 81930 | 6-Hydroxy-1-indanone | 62803-47-8 | 98% |  |
| Coming soon! | ||||
| 81003 | 2H-Isoindole-1-carboxylic acid methyl ester | 56365-71-0 | 97% |  |
| Coming soon! | ||||